Your hard-earned money would be better spent elsewhere.
On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...
For the past decade, we’ve been sold a seductive vision: the “smart city.” Gleaming control rooms, traffic lights that talk ...
Alongside this rapid progress, an equally ambitious effort has emerged to construct ethical frameworks for intelligent ...
Investor's Business Daily on MSN
AI stocks: Will self-improving models decide who wins superintelligence race?
Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.
Amazon Mechanical Turk shutdown ends 21 years of invisible labor that powered the AI training industry, as AWS closes the ...
Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...
OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results